Search research articles
Contact Us
Filters
Showing results (21-30 of 43) with videos related to
Page
of 5
Sort By:
Clinical Medicine (London, England)
|
January 22, 2021
Developing services for long COVID: lessons from a study of wounded healers
Emma Ladds, Alex Rushforth, Sietse Wieringa, et al.
Clinical Medicine (London, England)
|
March 25, 2021
Erratum: Developing services for long COVID: lessons from a study of wounded healers
Emma Ladds, Alex Rushforth, Sietse Wieringa, et al.
Journal of Neuroinflammation
|
October 2, 2017
The contribution of the acute phase response to the pathogenesis of relapse in chronic-relapsing experimental autoimmune encephalitis models of multiple sclerosis
Silvy Mardiguian, Emma Ladds, Roberta Turner, et al.
BMC Health Services Research
|
December 21, 2020
Persistent symptoms after Covid-19: qualitative study of 114 "long Covid" patients and draft quality principles for services
Emma Ladds, Alex Rushforth, Sietse Wieringa, et al.
Journal of Neuroinflammation
|
July 26, 2017
Erratum to: The role of PPAR activation during the systemic response to brain injury
Patrick Losey, Emma Ladds, Maud Laprais, et al.
Journal of Neuroinflammation
|
May 22, 2015
The role of PPAR activation during the systemic response to brain injury
Patrick Losey, Emma Ladds, Maud Laprais, et al.
BMJ Quality & Safety
|
March 9, 2022
Safety implications of remote assessments for suspected COVID-19: qualitative study in UK primary care
Sietse Wieringa, Ana Luisa Neves, Alexander Rushforth, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners
|
February 2, 2026
Teamwork and relational infrastructure: a qualitative study of modern UK general practice
Francesca H Dakin, Ninna Meier, Emma Ladds, et al.
Trials
|
August 20, 2021
SPIKE-1: A Randomised Phase II/III trial in a community setting, assessing use of camostat in reducing the clinical progression of COVID-19 by blocking SARS-CoV-2 Spike protein-initiated membrane fusion
Sarah Halford, Susan Wan, Ilaria Dragoni, et al.
Trials
|
April 22, 2022
Correction to: SPIKE-1: A Randomised Phase II/III trial in a community setting, assessing use of camostat in reducing the clinical progression of COVID-19 by blocking SARS-CoV-2 Spike protein-initiated membrane fusion
Sarah Halford, Susan Wan, Ilaria Dragoni, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 43) with videos related to
Sort By:
Page
of 5
Clinical Medicine (London, England)
|
January 22, 2021
Developing services for long COVID: lessons from a study of wounded healers
Emma Ladds, Alex Rushforth, Sietse Wieringa, et al.
Clinical Medicine (London, England)
|
March 25, 2021
Erratum: Developing services for long COVID: lessons from a study of wounded healers
Emma Ladds, Alex Rushforth, Sietse Wieringa, et al.
Journal of Neuroinflammation
|
October 2, 2017
The contribution of the acute phase response to the pathogenesis of relapse in chronic-relapsing experimental autoimmune encephalitis models of multiple sclerosis
Silvy Mardiguian, Emma Ladds, Roberta Turner, et al.
BMC Health Services Research
|
December 21, 2020
Persistent symptoms after Covid-19: qualitative study of 114 "long Covid" patients and draft quality principles for services
Emma Ladds, Alex Rushforth, Sietse Wieringa, et al.
Journal of Neuroinflammation
|
July 26, 2017
Erratum to: The role of PPAR activation during the systemic response to brain injury
Patrick Losey, Emma Ladds, Maud Laprais, et al.
Journal of Neuroinflammation
|
May 22, 2015
The role of PPAR activation during the systemic response to brain injury
Patrick Losey, Emma Ladds, Maud Laprais, et al.
BMJ Quality & Safety
|
March 9, 2022
Safety implications of remote assessments for suspected COVID-19: qualitative study in UK primary care
Sietse Wieringa, Ana Luisa Neves, Alexander Rushforth, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners
|
February 2, 2026
Teamwork and relational infrastructure: a qualitative study of modern UK general practice
Francesca H Dakin, Ninna Meier, Emma Ladds, et al.
Trials
|
August 20, 2021
SPIKE-1: A Randomised Phase II/III trial in a community setting, assessing use of camostat in reducing the clinical progression of COVID-19 by blocking SARS-CoV-2 Spike protein-initiated membrane fusion
Sarah Halford, Susan Wan, Ilaria Dragoni, et al.
Trials
|
April 22, 2022
Correction to: SPIKE-1: A Randomised Phase II/III trial in a community setting, assessing use of camostat in reducing the clinical progression of COVID-19 by blocking SARS-CoV-2 Spike protein-initiated membrane fusion
Sarah Halford, Susan Wan, Ilaria Dragoni, et al.
Page
of 5